SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
Activity window: Oct. 20, 2025 to Oct. 19, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Jun. 1, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jun. 1, 2026 CORRESP Neutral/Informational Moderate Brainstorm Cell Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. The company aims for t… Read Filing EDGAR
May. 27, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Chaim Lebovits, CEO of Brainstorm Cell Therapeutics Inc., that they will not review the company's registration statement filed on May 21, 2026. The let… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.